Researcher Profile

Researcher Profile

Qiushi Chen

Qiushi Chen

Assistant Professor, Marcus Department of Industrial and Manufacturing Engineering
Scientific Program:Cancer Control
qxc35@psu.edu

Research Interests

  • Therapeutics
  • Cost-Benefit Analysis
  • Hepatitis C
  • Hepacivirus
  • Costs and Cost Analysis
  • Antiviral Agents
  • Quality-Adjusted Life Years
  • Colorectal Neoplasms
  • Population
  • China
  • Pandemics
  • Cross-Sectional Studies

Recent Publications

2022

Chen, S, Forster, S, Yang, J, Yu, F, Jiao, L, Gates, J, Wang, Z, Liu, H, Chen, Q, Geldsetzer, P, Wu, P, Wang, C, McMahon, S, Bärnighausen, T & Adam, M 2022, 'Animated, video entertainment-education to improve vaccine confidence globally during the COVID-19 pandemic: an online randomized controlled experiment with 24,000 participants', Trials, vol. 23, no. 1, 161. https://doi.org/10.1186/s13063-022-06067-5
Mueller, PP, Chen, Q, Ayer, T, Nemutlu, GS, Hajjar, A, Bethea, ED, Peters, MLB, Lee, BP, Janjua, NZ, Kanwal, F & Chhatwal, J 2022, 'Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication', Journal of Hepatology, vol. 77, no. 1, pp. 55-62. https://doi.org/10.1016/j.jhep.2022.01.027
Liu, W, Yu, F, Geldsetzer, P, Yang, J, Wang, Z, Golden, T, Jiao, L, Chen, Q, Liu, H, Wu, P, Wang, C, Bärnighausen, T & Chen, S 2022, 'Prevalence of depression in China during the early stage of the COVID-19 pandemic: A cross-sectional study in an online survey sample', BMJ open, vol. 12, no. 3, e056667. https://doi.org/10.1136/bmjopen-2021-056667
Shahjouei, S, Li, J, Koza, E, Abedi, V, Sadr, AV, Chen, Q, Mowla, A, Griffin, P, Ranta, A & Zand, R 2022, 'Risk of Subsequent Stroke among Patients Receiving Outpatient vs Inpatient Care for Transient Ischemic Attack: A Systematic Review and Meta-analysis', JAMA network open, vol. 5, no. 1, 100193. https://doi.org/10.1001/jamanetworkopen.2021.36644
Chen, Q, Sterner, G, Segel, J & Feng, Z 2022, 'Trends in opioid-related crime incidents and comparison with opioid overdose outcomes in the United States', International Journal of Drug Policy, vol. 101, 103555. https://doi.org/10.1016/j.drugpo.2021.103555

2021

Adee, M, Zhuo, Y, Zhan, T, Chen, Q, Toumi, A, Ayer, T, Nwankwo, C, Zhong, H, Puenpatom, A & Chhatwal, J 2021, 'A Tool to Inform Hepatitis C Elimination: A Case for Hepatitis C Elimination in China', Clinical Liver Disease, vol. 17, no. 3, pp. 99-106. https://doi.org/10.1002/cld.1109
Chen, S, Chen, Q, Yang, J, Lin, L, Li, L, Jiao, L, Geldsetzer, P, Wang, C, Wilder-Smith, A & Bärnighausen, T 2021, 'Curbing the COVID-19 pandemic with facility-based isolation of mild cases: a mathematical modeling study', Journal of Travel Medicine, vol. 28, no. 2. https://doi.org/10.1093/jtm/taaa226
Yu, F, Geldsetzer, P, Meierkord, A, Yang, J, Chen, Q, Jiao, L, Abou-Arraj, NE, Pan, A, Wang, C, Bärnighausen, T & Chen, S 2021, 'Erratum: Correction: Knowledge About COVID-19 Among Adults in China: Cross-sectional Online Survey (Journal of medical Internet research (2021) 23 4 (e26940))', Journal of medical Internet research, vol. 23, no. 5, pp. e30100. https://doi.org/10.2196/30100
Yu, F, Geldsetzer, P, Meierkord, A, Yang, J, Chen, Q, Jiao, L, Abou-Arraj, NE, Pan, A, Wang, C, Bärnighausen, T & Chen, S 2021, 'Knowledge about COVID-19 among adults in China: Cross-sectional online survey', Journal of medical Internet research, vol. 23, no. 4, e26940. https://doi.org/10.2196/26940

2020

Chen, Q, Ayer, T, Adee, MG, Wang, X, Kanwal, F & Chhatwal, J 2020, 'Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma among Patients with Hepatitis C in the Era of Direct-Acting Antiviral Agents', JAMA network open, vol. 3, no. 11, e2021173. https://doi.org/10.1001/jamanetworkopen.2020.21173
Chen, S, Chen, Q, Yang, W, Xue, L, Liu, Y, Yang, J, Wang, C & Bärnighausen, T 2020, 'Buying Time for an Effective Epidemic Response: The Impact of a Public Holiday for Outbreak Control on COVID-19 Epidemic Spread', Engineering, vol. 6, no. 10, pp. 1108-1114. https://doi.org/10.1016/j.eng.2020.07.018
Zhuo, Y, Hayashi, T, Chen, Q, Aggarwal, R, Hutin, Y & Chhatwal, J 2020, 'Estimating the price at which hepatitis C treatment with direct-acting antivirals would be cost-saving in Japan', Scientific reports, vol. 10, no. 1, 4089. https://doi.org/10.1038/s41598-020-60986-4

2019

Çağlayan, Ç, Terawaki, H, Ayer, T, Goldstein, JS, Rai, A, Chen, Q & Flowers, C 2019, 'Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model', Clinical Lymphoma, Myeloma and Leukemia, vol. 19, no. 5, pp. 300-309.e5. https://doi.org/10.1016/j.clml.2018.12.019
Chhatwal, J, Chen, Q, Wang, X, Ayer, T, Zhuo, Y, Janjua, NZ & Kanwal, F 2019, 'Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan', JAMA network open, vol. 2, no. 5, pp. e193613. https://doi.org/10.1001/jamanetworkopen.2019.3613
Chen, Q, Ayer, T, Bethea, E, Kanwal, F, Wang, X, Roberts, M, Zhuo, Y, Fagiuoli, S, Petersen, J & Chhatwal, J 2019, 'Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: A modelling study', BMJ open, vol. 9, no. 6, e026726. https://doi.org/10.1136/bmjopen-2018-026726
Chen, Q, Larochelle, MR, Weaver, DT, Lietz, AP, Mueller, PP, Mercaldo, S, Wakeman, SE, Freedberg, KA, Raphel, TJ, Knudsen, AB, Pandharipande, PV & Chhatwal, J 2019, 'Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States', JAMA network open, vol. 2, no. 2, pp. e187621. https://doi.org/10.1001/jamanetworkopen.2018.7621
Chhatwal, J, Chen, Q, Bethea, ED, Hur, C, Spaulding, AC & Kanwal, F 2019, 'The impact of direct-acting anti-virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States', Alimentary Pharmacology and Therapeutics, vol. 50, no. 1, pp. 66-74. https://doi.org/10.1111/apt.15291

2018

Goel, A, Chen, Q, Chhatwal, J & Aggarwal, R 2018, 'Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 33, no. 12, pp. 2029-2036. https://doi.org/10.1111/jgh.14301
Chen, Q, Zhao, L, Fransoo, JC & Li, Z 2019, 'Dual-mode inventory management under a chance credit constraint', OR Spectrum, vol. 41, no. 1, pp. 147-178. https://doi.org/10.1007/s00291-018-0532-4
Chhatwal, J, Chen, Q & Aggarwal, R 2018, 'Estimation of Hepatitis C Disease Burden and Budget Impact of Treatment Using Health Economic Modeling', Infectious Disease Clinics of North America, vol. 32, no. 2, pp. 461-480. https://doi.org/10.1016/j.idc.2018.02.008
Chen, Q, Staton, AD, Ayer, T, Goldstein, DA, Koff, JL & Flowers, CR 2018, 'Exploring the potential cost-effectiveness of precision medicine treatment strategies for diffuse large B-cell lymphoma', Leukemia and Lymphoma, vol. 59, no. 7, pp. 1700-1709. https://doi.org/10.1080/10428194.2017.1390230
Chhatwal, J, Chen, Q, Bethea, ED, Ladd, MA, Mueller, PP, Hutin, Y & Aggarwal, R 2018, 'Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs', The Lancet Gastroenterology and Hepatology, vol. 3, no. 12. https://doi.org/10.1016/S2468-1253(18)30281-4
Chhatwal, J, Chen, Q, Ayer, T, Bethea, ED, Kanwal, F, Kowdley, KV, Wang, X, Roberts, MS & Gordon, SC 2018, 'Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA', Alimentary Pharmacology and Therapeutics, vol. 47, no. 7, pp. 1023-1031. https://doi.org/10.1111/apt.14527
Çağlayan, Ç, Terawaki, H, Chen, Q, Rai, A, Ayer, T & Flowers, CR 2018, 'Microsimulation modeling in oncology', JCO Clinical Cancer Informatics, vol. 2018, no. 2, pp. 1-11. https://doi.org/10.1200/CCI.17.00029
Chen, Q, Ayer, T & Chhatwal, J 2018, 'Optimal M-switch surveillance policies for liver cancer in a hepatitis C-infected population', Operations Research, vol. 66, no. 3, pp. 673-696. https://doi.org/10.1287/opre.2017.1706
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Reply', Hepatology, vol. 67, no. 4, pp. 1641-1642. https://doi.org/10.1002/hep.29770
Bethea, ED, Chen, Q, Hur, C, Chung, RT & Chhatwal, J 2018, 'Should we treat acute hepatitis C? A decision and cost-effectiveness analysis', Hepatology, vol. 67, no. 3, pp. 837-846. https://doi.org/10.1002/hep.29611

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)